Title:
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS
Document Type and Number:
Japanese Patent JP2021045124
Kind Code:
A
Abstract:
To provide peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods, in particular, treatment of NHL.SOLUTION: The present invention relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.SELECTED DRAWING: None
More Like This:
Inventors:
SCHOOR OLIVER
ANDREA MAHR
WEINSCHENK TONI
ANITA WIEBE
JENS FRITSCHE
SINGH HARPREET
ANDREA MAHR
WEINSCHENK TONI
ANITA WIEBE
JENS FRITSCHE
SINGH HARPREET
Application Number:
JP2020163155A
Publication Date:
March 25, 2021
Filing Date:
September 29, 2020
Export Citation:
Assignee:
IMMATICS BIOTECHNOLOGIES GMBH
International Classes:
C12N15/115; A61K9/08; A61K9/19; A61K31/7088; A61K35/15; A61K35/17; A61K35/76; A61K38/08; A61K38/10; A61K39/00; A61K39/395; A61K48/00; A61K51/10; A61P35/00; A61P35/02; C07K7/06; C07K7/08; C07K14/725; C07K16/30; C07K19/00; C12N5/10; C12N15/12; C12N15/62; C12N15/85; C12P21/02; G01N33/574
Foreign References:
| WO2001000673A1 | 2001-01-04 | |||
| US20120010385A1 | 2012-01-12 |
Attorney, Agent or Firm:
Takashi Shoji